Interesting update from Charles Russell on the CJEU's decision re Brustle, the patentability of ESC and whether parthenogenetic stem cells are fundamentally different to ESC

Interesting update from Charles Russell on the CJEU's decision re Brustle, the patentability of ESC and whether parthenogenetic stem cells are fundamentally different to ESC.

Court is due to meet for the end of April 2014.

http://www.mondaq.com/x/304612/Life+Sciences+Biotechnology/The+CJEUs+Decision+In+Brustle+The+Implications+For+Stem+Cell+Research